Abstract
Parkinson's disease has a high prevalence of psychiatric comorbidity including depression. This review highlights the epidemiology, aetiology and diagnosis of depression in patients with Parkinson's disease. Recommendations are made on treatment and a closer partnership between neurology and psychiatry.
MeSH terms
-
Antidepressive Agents / adverse effects
-
Antidepressive Agents / therapeutic use*
-
Antiparkinson Agents / adverse effects
-
Depressive Disorder / diagnosis
-
Depressive Disorder / drug therapy*
-
Depressive Disorder / etiology
-
Humans
-
Parkinson Disease / complications*
-
Parkinson Disease / psychology
-
Risk Factors
Substances
-
Antidepressive Agents
-
Antiparkinson Agents